Explore MedTech Virtual Event: U.S. Healthcare Payer Adoption - Key to Coverage Post FDA Approval

Posted Mar 16th, 2023

Achieving timely positive coverage determinations from payors is a critical success factor that many non-drug medical technologies innovators do not adequately prepare for when entering the U.S. market. A panel of expert stakeholders from a U.S. Payor, FDAs Early Payor Feedback Program, EXCITE International and an innovative company will discuss the situation and solutions that adoption decision-makers have developed to deal with the situation.


• Laurel Soot, M.D., VP Medical Management, Providence Health Plan.

• Kelly Wilkicki, Senior Advisor for Innovation FDA/CDRH

• Leslie Levin, M.D., CEO and Chief Scientific Officer EXCITE International

• Geir Almas, Executive Chairman, SoftOx Solutions

Moderated by Raj Malik, VP of Federal Affairs and National Strategic Partnerships. Medtech Canada

RSVP here: https://forms.gle/aNAF9vrLPYtEsVFq7

Work with us. EXCITE International can assist you in facilitating multi-jurisdictional clinical trials through its partnership with government, clinical experts, methodology centres and health system decision makers.